PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extracts showed inhibitory concentrations (IC50) for killing 50% of HeLa (1.020 mg/mL) and Hep-G2 (1.507 mg/mL) cells after 24h [PMID:32114858]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 15220396 (2004) — Inheritance of egusi seed type in watermelon. · The Journal of heredity
- 2.PMID: 34927761 (2022) — Egusi seed allergy confirmed using the basophil activation test. · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
- 3.PMID: 34441594 (2021) — Physicochemical, Mineral and Sensory Characteristics of Instant Citrullus lanatus mucosospermus (Egusi) Soup. · Foods (Basel, Switzerland)
- 4.PMID: 40182542 (2025) — Unlocking the potential of 'Egusi' melon (Colocynthis citrullus L.) as a crop for biotechnological improvement. · Frontiers in plant science
- 5.PMID: 22540530 (2012) — Oil and fatty acid contents in seed of Citrullus lanatus Schrad.